FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Lululemon Athletica Appoints Ex. Nike Executive Heidi O'neill As Ceo

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Lululemon announced Heidi O'Neill as its next CEO effective September 8, 2026, following a search process after Calvin McDonald's departure in January amid pressure from founder Chip Wilson and activist investor Elliott Management. O'Neill brings over 30 years of performance apparel experience, including 25+ years at Nike where she helped grow the company from a $9B to $45B global leader and most recently served as President, Consumer, Product & Brand. We are in favor of the decision and believe her extensive Nike background and current board positions at Spotify, Hyatt, and Lithia & Driveway make her a well-rounded candidate to guide the turnaround at lululemon. Shares fell 5% in after-hours trading as investors digest the announcement, most likely due to Nike's share decline during her recent tenure there. Her experience overseeing Nike's global consumer and product engine, resetting brand foundation, and reducing product development timelines should accelerate speed to market at LULU.

Related Articles

Asia

Victory Giant Technology Nets HK$3 Billion From Full Exercise of IPO Over-Allotment Option

Victory Giant Technology (HKG:2476, SHE:300476) said the overallotment option of its Hong Kong initial public offering was fully exercised on Wednesday, according to a same-day Hong Kong bourse filing.The China-based printed circuit board manufacturer expects to raise about HK$3 billion in additional net proceeds.The exercise involved the issue of 14.4 million additional shares at HK$209.88 each, representing about 15% of the total offer shares available under the global offering.Dealings in the over-allotment shares are expected to begin on April 27, the filing said.

$HKG:2476$SHE:300476
Asia

Arovella Therapeutics Says Requisitioning Shareholder Withdraws Notice, Shares Fall 3%

Arovella Therapeutics (ASX:ALA) said the requisitioning shareholder has withdrawn its April 8 notice, which called for a general meeting to appoint three directors, according to a Thursday Australian bourse filing.Arovella Therapeutics had earlier said the notice "cannot be lawfully effected at a general meeting," and had invited the shareholder to formally withdraw the notice.Its shares fell 3% in recent trading on Thursday.

$ASX:ALA
Asia

Lantian Tech's 2025 Profit Slips 3%, Revenue Rises 5%

CETC Lantian Technology's (SHA:688818) net profit attributable to shareholders in 2025 slipped 3% to 327.1 million yuan from 337.2 million yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share fell 4.5% year on year to 0.21 yuan from 0.22 yuan.Operating revenue rose 5.1% to 3.29 billion yuan from 3.13 billion yuan in the previous year.

$SHA:688818